Wolfe Research Maintains Outperform on Kaspi.kz, Raises Price Target to $115
Wolfe Research analyst Darrin Peller maintains Kaspi.kz (NASDAQ:KSPI) with a Outperform and raises the price target from $110 to $115.
Stocks · News reference
Top 3 Financial Stocks That May Fall Off A Cliff In August
Be cautious of momentum-based trading decisions for financial sector stocks. RSI indicator shows overbought conditions for MKTX, KSPI, and PAYS.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Susquehanna Maintains Neutral on Kaspi.kz, Raises Price Target to $100
Susquehanna analyst James Friedman maintains Kaspi.kz (NASDAQ:KSPI) with a Neutral and raises the price target from $95 to $100.
Kaspi.Kz shares are trading higher after the company reported better-than-expected Q2 EPS results.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Personalis (acquired by Tempus AI for $16.25/share), Werewolf Therapeutics (acquired by Ambros Therapeutics), Beazer Homes (acquired by Dream Finders Homes for $33.50/share), and MarketAxess Holdings (acquired by Intercontinental Exchange for $167/share).
Here's Why Investors Should Stay Neutral on MarketAxess Stock for Now
MarketAxess (MKTX) is diversifying beyond U.S. credit with international expansion and new trading protocols, with non-U.S. credit revenues rising 9%. However, U.S. credit revenues declined 9%, and the stock carries an elevated forward P/E of 19.08X above industry average. The company maintains strong financials and consistent earnings beats, but faces risks from trading volume sensitivity and investment costs, warranting a neutral stance.
Top 3 Financial Stocks That Could Sink Your Portfolio In Q3
Three financial stocks are showing overbought signals, indicating short-term downside potential for momentum traders. RSI values and prices included.